{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:33:04Z","timestamp":1770967984994,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00280-023-04525-8","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T11:04:46Z","timestamp":1679569486000},"page":"331-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of pre-hydration duration on high-dose methotrexate induced nephrotoxicity in childhood acute lymphoblastic leukaemia in resource constraint centers: a randomized crossover study"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4754-8340","authenticated-orcid":false,"given":"Sanjeev","family":"Khera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapil","family":"Barbind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"issue":"9","key":"4525_CR1","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","volume":"104","author":"CH Pui","year":"2004","unstructured":"Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC et al (2004) Improved outcome for children with acute lymphoblastic leukemia: results of total therapy study XIIIB at St Jude children\u2019s research hospital. Blood 104(9):2690\u20132696","journal-title":"Blood"},{"issue":"12","key":"4525_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","volume":"21","author":"SC Howard","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD (2016) Preventing and managing toxicities of high-dose methotrexate. Oncologist 21(12):1471\u20131482","journal-title":"Oncologist"},{"issue":"7","key":"4525_CR3","doi-asserted-by":"publisher","first-page":"e28387","DOI":"10.1002\/pbc.28387","volume":"67","author":"S Khera","year":"2020","unstructured":"Khera S, Kapoor R, Pramanik SK (2020) Solitary serum methotrexate level 36 hours post high-dose methotrexate: a safe, efficacious, and cost-effective strategy to monitor methotrexate toxicities in childhood leukemia in resource-limited centers. Pediatr Blood Cancer 67(7):e28387","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"4525_CR4","doi-asserted-by":"publisher","first-page":"e27241","DOI":"10.1002\/pbc.27241","volume":"65","author":"K Vaishnavi","year":"2018","unstructured":"Vaishnavi K, Bansal D, Trehan A, Jain R, Attri SV (2018) Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin. Pediatr Blood Cancer 65(12):e27241","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"4525_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1200\/JCO.1988.6.5.797","volume":"6","author":"ML Christensen","year":"1988","unstructured":"Christensen ML, Rivera GK, Crom WR, Hancock ML, Evans WE (1988) Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia. J Clin Oncol 6(5):797\u2013801. https:\/\/doi.org\/10.1200\/JCO.1988.6.5.797. (PMID: 3163362)","journal-title":"J Clin Oncol"},{"key":"4525_CR6","unstructured":"ALL IC-BFM (2009) A randomized trial of the I-BFM-SG for the management of childhood non-B acute lymphoblastic leukemia. Final Version of Therapy Protocol from August-14-2009. https:\/\/www.bialaczka.org\/wp-content\/uploads\/2016\/10\/ALLIC_BFM_2009.pdf"},{"issue":"12","key":"4525_CR7","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.3109\/10428194.2014.898143","volume":"55","author":"M Karremann","year":"2014","unstructured":"Karremann M, Sauerbier J, Meier C, Vetter C, Schneider H, Buchholz B, Mildenberger S, D\u00fcrken M (2014) The impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patients. Leuk Lymphoma 55(12):2874\u20132878. https:\/\/doi.org\/10.3109\/10428194.2014.898143. (Epub 2014 Apr 2 PMID: 24576168)","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"4525_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12185-013-1464-z","volume":"98","author":"M Yanagimachi","year":"2013","unstructured":"Yanagimachi M, Goto H, Kaneko T, Naruto T, Sasaki K, Takeuchi M, Tanoshima R, Kato H, Yokosuka T, Kajiwara R, Fujii H, Tanaka F, Goto S, Takahashi H, Mori M, Kai S, Yokota S (2013) Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy. Int J Hematol 98(6):702\u2013707. https:\/\/doi.org\/10.1007\/s12185-013-1464-z. (Epub 2013 Nov 16 PMID: 24241962)","journal-title":"Int J Hematol"},{"key":"4525_CR9","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.2147\/CMAR.S172117","volume":"10","author":"C Traivaree","year":"2018","unstructured":"Traivaree C, Likasitthananon N, Monsereenusorn C, Rujkijyanont P (2018) The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients. Cancer Manag Res 10:4471\u20134478","journal-title":"Cancer Manag Res"},{"key":"4525_CR10","unstructured":"(2017) Common terminology criteria for adverse events (CTCAE). 147"},{"issue":"6","key":"4525_CR11","doi-asserted-by":"publisher","first-page":"e8674","DOI":"10.7759\/cureus.8674","volume":"12","author":"AR Chen","year":"2020","unstructured":"Chen AR, Wang YM, Lin M, Kuo DJ (2020) High-dose methotrexate in pediatric acute lymphoblastic leukemia: predictors of delayed clearance and the effect of increased hydration rate on methotrexate clearance. Cureus 12(6):e8674. https:\/\/doi.org\/10.7759\/cureus.8674","journal-title":"Cureus"},{"issue":"2","key":"4525_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/pbc.24623","volume":"61","author":"TS Mikkelsen","year":"2014","unstructured":"Mikkelsen TS, Mamoudou AD, Tuckuviene R, Wehner PS, Schroeder H (2014) Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study. Pediatr Blood Cancer 61(2):297\u2013301. https:\/\/doi.org\/10.1002\/pbc.24623. (Epub 2013 Sep 3 PMID: 24039194)","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4525_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12288-019-01144-3","volume":"36","author":"M Sajith","year":"2020","unstructured":"Sajith M, Pawar A, Bafna V, Bartakke S, Subramanian K, Vaidya N (2020) Serum methotrexate level and side effects of high dose methotrexate infusion in pediatric patients with acute lymphoblastic Leukaemia (ALL). Indian J Hematol Blood Transfus 36(1):51\u201358. https:\/\/doi.org\/10.1007\/s12288-019-01144-3","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"1","key":"4525_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00280-013-2319-2","volume":"73","author":"W Xu","year":"2014","unstructured":"Xu W, qun, Zhang L yan, Chen X ying, Pan B hua, Mao J qing, Song H, et al (2014) Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies. Cancer Chemother Pharmacol 73(1):79\u201386","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"4525_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29738","volume":"69","author":"S Khera","year":"2022","unstructured":"Khera S, Sharma G, Negi V, Shaw SC (2022) Hypoalbuminemia and not undernutrition predicts high-dose methotrexate-induced nephrotoxicity in children with acute lymphoblastic leukemia in resource-constrained centers. Pediatr Blood Cancer 69(9):e29738","journal-title":"Pediatr Blood Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-023-04525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-023-04525-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-023-04525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T06:15:33Z","timestamp":1680502533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-023-04525-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["4525"],"URL":"https:\/\/doi.org\/10.1007\/s00280-023-04525-8","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"28 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}